BSE filing, NSE: CORONA. Summary written from the filing by ALFA Finder's alert engine.
Corona Remedies Ltd: key numbers
- Share price
- ₹2,175.00
- Market cap
- ₹13,302 Cr
- Revenue (annual)
- ₹1,403 Cr
- Net profit (annual)
- ₹185.1 Cr
- P/E (TTM)
- 66.8×Sector 48.7×
- Promoter holding
- 69.00%+0.00% QoQ
- FII holding
- 4.21%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Corona Remedies Ltd
All →Corona Remedies Results Update
Corona Remedies released unaudited Q2 and H1 FY27 results highlights via press release. Revenue grew 22% year on year, with EBITDA and PAT also rising.
Corona Remedies Q2 FY27 Results: Net Profit ₹60.3 Cr, Up 15.3% YoY
Corona Remedies Ltd reported revenue from operations of ₹441.2 Cr (+22.2% YoY) and net profit of ₹60.3 Cr (+15.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹60.3 Cr · +15.3% YoY
Corona Remedies Business Update
Corona Remedies received GMP Compliance Certification from Brazil's ANVISA for its OSD and Hormone facilities in Ahmedabad. This validates export eligibility to the Brazilian pharmaceutical market.
Corona Remedies Board Meeting Date
Corona Remedies Limited will hold a board meeting on October 30, 2026. The board will consider unaudited financial results for the quarter and half-year ended September 30, 2026.
Corona Remedies Other Announcement
This filing contains quarterly shareholding pattern disclosures for Corona Remedies Ltd. It provides details on share distribution as required by regulatory compliance norms.
Corona Remedies Credit Rating
CARE Ratings has reaffirmed and upgraded the credit ratings assigned to Corona Remedies Limited's bank facilities, as disclosed in the latest regulatory filing.
Other annual report announcements
All →Milestone Furniture Annual Report
Milestone Furniture published its 12th Annual Report for FY2025-26 with AGM notice for 21 November 2026. Agenda covers accounts, auditor appointment, capital increase and director appointments.
CMX Holdings Annual Report
Riwind Green Energy (formerly CMX Holdings) submitted its 35th Annual Report for FY 2025-26, acknowledging a delay in filing. The AGM was held on 30 September 2026.
Aesthetik Engineers Annual Report
Aesthetik Engineers filed its Integrated Annual Report for FY2025-26 with the 18th AGM notice. The AGM will be held on November 28, 2026 via video conferencing.
Evexia Lifecare Annual Report
Evexia Lifecare filed its FY 2025-26 Annual Report ahead of its 35th AGM on 30 September 2026. It contains financial and governance disclosures, with no new transaction.
Ardee Industries Annual Report
Ardee Industries filed its FY 2025-26 Annual Report and 33rd AGM notice under Regulation 34(1). The submission includes audited financials, governance and MD&A reports.
Vashu Bhagnani Industries Annual Report
Vashu Bhagnani Industries Limited has uploaded its FY 2025-26 Annual Report, with the AGM notice, to the Annual Report tab for record completeness. The content is unchanged from the 1 September 2026 submission.